NCT03649971 2025-02-03A Study of Guselkumab in Participants With Familial Adenomatous PolyposisJanssen Research & Development, LLCPhase 1 Completed77 enrolled
NCT04948398 2025-02-03Post-Trial Access for Guselkumab in Participants With Familial Adenomatous PolyposisJanssen Research & Development, LLCNo longer available